Structure

InChI Key CITWCLNVRIKQAF-UHFFFAOYSA-N
Smiles N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(OCCO)cc1
InChI
InChI=1S/C25H18ClN5O2S2/c26-17-5-1-16(2-6-17)24-30-18(13-34-24)14-35-25-21(12-28)22(20(11-27)23(29)31-25)15-3-7-19(8-4-15)33-10-9-32/h1-8,13,32H,9-10,14H2,(H2,29,31)

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H18ClN5O2S2
Molecular Weight 520.04
AlogP 5.51
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 8.0
Polar Surface Area 128.84
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 35.0

Bioactivity

Mechanism of Action Action Reference
Adenosine A1 receptor partial agonist PARTIAL AGONIST PubMed PubMed
Protein: Adenosine A1 receptor

Description: Adenosine receptor A1

Organism : Homo sapiens

P30542 ENSG00000163485
Assay Description Organism Bioactivity Reference
Agonist activity at adenosine A1 receptor (unknown origin) expressed in CHO cells assessed as increase in intracellular cAMP level by RIA Homo sapiens 0.1 nM
Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cell membranes by competition association assay Homo sapiens 1.4 nM
Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in HEK293 cell membranes at 1 uM by competition association assay Homo sapiens 0.0 %
Displacement of [3H]PSB603 from human adenosine A2B receptor expressed in CHO cell membranes at 1 uM by competition association assay Homo sapiens 2.5 %
Displacement of [3H]PSB11 from human adenosine A3 receptor expressed in CHO cell membranes at 1 uM by competition association assay Homo sapiens 1.2 %
Agonist activity at human adenosine A1 receptor expressed in CHO cell membranes by [35S]GTPgammaS binding assay Homo sapiens 1.1 nM
Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cell membranes at 1 uM by competition association assay Homo sapiens 80.0 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 5.43 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 1.083 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.26 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.26 %

Cross References

Resources Reference
ChEMBL CHEMBL3235279
DrugBank DB16118
FDA SRS O519NVW73R
Guide to Pharmacology 11221
PubChem 9936489
SureChEMBL SCHEMBL174016
ZINC ZINC000043202900